Drug Trial Radar · NCT00116350
Misoprostol for the Treatment of Postpartum Hemorrhage
Last checked: Nov 19, 2026Latest source record: Mar 19, 2009 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,786
Actual
Start
Jul 2005
Primary completion
Jan 2008
Study completion Jan 2008
Sponsor
- Lead sponsor
- Gynuity Health ProjectsAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Family Care International
- First posted
- Jun 29, 2005
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- Who can join
- Female only
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to test whether misoprostol is as effective as oxytocin for treating primary postpartum hemorrhage (PPH) with uterine atony as the suspected cause in two circumstances: 1) where women have received prophylactic uterotonics in the third stage of labor; and 2) where no prophylactic uterotonics have been given in the third stage of labor.
Conditions
- Postpartum Hemorrhage
Interventions
MisoprostolDrug
800 mcg sublingual misoprostol
OxytocinDrug
40 IU Oxytocin IV
Primary outcomes
What the sponsor says the trial is designed to measure.
- Need for additional treatment after initial PPH study treatmentTime frame: all additional interventions recorded following initial uterotonic treatment
Locations
6 sites in 5 countries. Site status is shown where the registry gives one.
Centre Hospitalier Universitaire Souro Sanou de Bobo Dioulasso
Bobo Diolasso, Burkina Faso
Hospital Gineco-Obstetrico Isidro Ayora
Quito, Ecuador
Alexandria University Hospital, Shatby Maternity Hospital
Alexandria, Egypt
El-Galaa Teaching Hospital
Cairo, Egypt
Ministry of Health Ankara Etlik Maternity and Teaching-Research Hospital
Ankara, Turkey (Türkiye)
Cu Chi Hospital, Tu Du Hospital, Hocmon Hospital, Binh Duong Hospital
Ho Chi Minh City and Binh Duong Province, Vietnam
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.